Triglycerides

 
Home > Low Triglycerides Information > Low Triglycerides News

Low Triglycerides News

  • Manage your diabetes, save your kidneys Saturday, November 15, 2008 @ 6:57PMManaging your diabetes properly can prevent or slow down kidney disease.
  • Increased nonfasting triglyceride levels associated with higher risk of stroke Tuesday, November 11, 2008 @ 4:31PMElevated nonfasting triglyceride levels, previously associated with an increased risk for heart attack, also appear to be associated with an increased risk for ischemic stroke, according to a study in the Nov. 12 issue of JAMA.
  • Increased Nonfasting Triglyceride Levels Associated With Higher Risk of Stroke Tuesday, November 11, 2008 @ 4:26PMElevated nonfasting triglyceride levels, previously associated with an increased risk for heart attack, also appear to be associated with an increased risk for ischemic stroke, according to a study in the November 12 issue of JAMA.
  • Perfected Nutrients Redefines the Protein Supplement Market With Its Hypoallergenic Nutribody Protein Tuesday, October 21, 2008 @ 8:04AM Finally, a protein drink debuts with no dairy, soy, whey, cholesterol, sodium, sugar, preservatives, or artificial sweeteners. Working in tandem with one of America's top Pro Cycling Teams, Perfected Nutrients™, a new functional food and beverage company, has taken a whole new approach to protein consumption by creating Nutribody Protein -- a convenient, tasty, hypoallergenic protein powder ...
  • Perfected Nutrients Redefines the Protein Supplement Market With Its Hypoallergenic Nutribody Protein Tuesday, October 21, 2008 @ 8:00AM Finally, a protein drink debuts with no dairy, soy, whey, cholesterol, sodium, sugar, preservatives, or artificial sweeteners.
  • US FDA approves Reyataz-Ritonavir combination therapy for HIV-1 Sunday, October 5, 2008 @ 11:47PMBristol-Myers Squibb Company announced that the US Food & Drug Administration (FDA) approved the use of Reyataz (atazanavir sulfate) 300 mg once-daily boosted with ritonavir 100 mg as part of combination therapy in previously untreated (treatment-naive) HIV-1 infected patients.
  • Sciele Pharma Announces That Plethora Solutions Has Completed European Phase III Trial of PSD502 for Premature ... Tuesday, September 30, 2008 @ 3:16PMSciele Pharma, Inc. ("Sciele") (NASDAQ:SCRX), a specialty pharmaceutical company, today announced that Plethora Solutions Holdings PLC ("Plethora") (AIM:PLE), the specialist developer of products for the treatment and management of urological disorders, has completed its European Phase III study of PSD502 for the treatment of premature ejaculation (PE) in Europe. The study was initiated in ...
  • Embracing menopause Tuesday, September 30, 2008 @ 5:11AMThe baby boomer generation coming of age brought the issue of menopause - "the change of life" - out in the open.
  • What Is The Main Risk Factor Of Gallstone Disease? Monday, September 22, 2008 @ 6:13AMGallstone disease is a very common gastrointestinal disorder: in fact it has been documented that more than 14% of adults are, or have been, affected by this disease. Therefore, gallstones are a major public health problem, and this disorder is one of the most common and costly of all digestive diseases, at least in the Western World.
  • Family Health:Take Charge! Know your risks and warning signs of heart trouble Monday, September 22, 2008 @ 1:03AMHeart disease has become a leading cause of disability and death in the Mid-South. Compared to U.S. averages, heart disease is far more common among people in the South.
  • Peek at the Week Thursday, August 21, 2008 @ 5:33AM Deadline for items for Peek at the Week is 10 days before desired publication date. Send information on fund-raisers, clubs, lectures, community events, church events, reunions and support groups to Peek at the Week, Pioneer Press, 130 S. Prospect Ave., Park Ridge, IL 60068, fax to (847) 696-3229, or e-mail to mbottari@pioneerlocal.com. There is no charge for publication.
  • Obese people can be healthy too Tuesday, August 12, 2008 @ 7:21PMSOME obese people are in good health and are not predisposed to heart ailments, according to a new study.
  • Obese people can be healthy too Tuesday, August 12, 2008 @ 6:37PMSOME obese people are in good health and are not predisposed to heart ailments, while being slim doesn't automatically protect you from heart-related illnesses.
  • Breakfast Eggs Keep Folks on Diet Tuesday, August 12, 2008 @ 5:00PMCopyright © 2008 ScoutNews LLC. All rights reserved. TUESDAY, Aug. 12 (HealthDay News) -- Eating eggs may help overweight adults lose weight and feel more energetic, according to U.S. researchers.
  • Obese people can be healthy: study Tuesday, August 12, 2008 @ 3:49PMA woman stands outside a sandwich shop. Some obese people are in good health and are not predisposed to heart ailments, according to a surprise study published in the Archives of Internal Medicine.
  • Obese people can be healthy: study Tuesday, August 12, 2008 @ 3:33PM Some obese people are in good health and are not predisposed to heart ailments, according to a surprise study published in the Archives of Internal Medicine.
  • Living Well: Cholesterol drugs for kids? Are they serious? Tuesday, August 12, 2008 @ 2:29PMLiving Well: Should you be worried about a recent recommendation that cholesterol drugs are appropriate for kids 8 years and older?
  • Obesity Not Always Linked To Higher Cardiovascular Risk Tuesday, August 12, 2008 @ 1:02PMTwo studies, one from Germany and another from the US published this week, suggest that obese people do not always carry an increased risk of heart disease, while some individuals of normal weight do. The clue appeared to lie in how body fat was distributed, for example fat in the abdomen, as indicated by a larger waist circumference, was a consistent risk factor in both studies.
  • Extra pounds don’t always increase risk to heart, study says Tuesday, August 12, 2008 @ 10:04AMOne in three obese Americans appears to have no increased signs of heart risks, according to a study that contradicts conventional wisdom and suggests standard tests can identify which fat people face a higher chance of developing cardiac disease.
  • Fat folks can be healthy too Tuesday, August 12, 2008 @ 6:00AMWashington, Aug 12 : Doctors keep suggesting that it's unhealthy to be overweight. And, for many people, that's true. But two new studies show that it's the location of the fat that matters. You can be normal weight and be just as bad off as a tubby next door.
  • Vitamin B3 Sunday, August 10, 2008 @ 4:14AMVitamin B 3 is required for the proper function of more than 50 enzymes. Without it, your body would not be able to release energy or make fats from carbohydrates.
  • People With Heart Disease Still Have Trouble Controlling Blood Lipid Levels Saturday, August 9, 2008 @ 8:30AMDespite some improvements to lower "bad" cholesterol levels, people with cardiovascular diseases still need to do a better job controlling overall blood lipid levels.
  • New Data Shows HIV Therapy Tipranavir (Aptivus®) Is Effective And Well Tolerated In Children Saturday, August 9, 2008 @ 4:19AMBoehringer Ingelheim presented new 100 week data at the International AIDS Conference demonstrating Aptivus® (tipranavir) long-term efficacy and safety in treatment-experienced children. Results from this two-year study show that Aptivus® enabled the children to achieve sustained virologic and immunologic responses and was a well-tolerated antiretroviral therapy.
  • Ex-NFL Players Participate in Lifesaving Health Screenings at Heart Check and GW Medical Faculty Associates Thursday, August 7, 2008 @ 10:01AM When you see professional football players on the field they appear invincible, but life after football often means they may be more vulnerable to health problems than the fans watching them every Sunday.
  • YOU ARE HERE: Wednesday, August 6, 2008 @ 4:46AMEfavirenz treatment results in a significantly higher rate of viral suppression after 48 weeks when compared to lopinavir/ritonavir, investigators of a randomised study among Mexican patients with very advanced HIV disease reported on Tuesday at the XVII International Conference on AIDS in Mexico City.
  • Eating breakfast eggs helps weight loss Wednesday, August 6, 2008 @ 12:36AMBATON ROUGE, La., Aug. 6 (UPI) -- Eating two eggs for breakfast helps overweight adults lose more weight and feel energetic than eating a bagel breakfast, U.S. researchers said.
  • Growth Hormone Treatment For HIV Patients Improves Abdominal Fat, But Worsens Glucose Level Tuesday, August 5, 2008 @ 10:32PMFor human immunodeficiency virus-infected patients with treatment-related abdominal obesity and growth hormone deficiency, receiving low-dose growth hormone resulted in improvement in fat and blood pressure measurements but worsened glucose levels, according to a study in the Aug. 6 issue of JAMA, a theme issue on HIV/AIDS.
  • Growth hormone's results mixed in HIV patients Tuesday, August 5, 2008 @ 7:44PM SUMMARY: Fat deposits on internal organs, a common HIV-drug side effect, are quelled 10 percent by low doses of human growth hormone, scientists say in Mexico City.
  • BioWorld International Correspondent Tuesday, August 5, 2008 @ 6:50PMShares in Karo Bio AB gained almost 30 percent this week on news that the company's lead drug candidate, the thyroid hormone receptor agonist eprotirome (KB2115) attained the primary endpoints in a Phase IIb trial in patients with elevated blood lipids who already were receiving statins.
  • ISENTRESS(R) (raltegravir), Merck's First in Class Integrase Inhibitor, Reduced HIV Viral Load and Increased CD4 Cell ... Tuesday, August 5, 2008 @ 12:26PMISENTRESS(R) (raltegravir), Merck & Co., Inc.'s first-in-class integrase inhibitor, in combination with two other anti-HIV medicines, reduced HIV viral load to undetectable levels (less than 50 copies/mL) in 83 percent of previously untreated (treatment-naive) HIV-infected patients which was comparable to that seen with efavirenz (Sustiva(R)/STOCRIN(R))*, which reduced HIV viral load to ...
  • ISENTRESS(R) (raltegravir), Merck's First in Class Integrase Inhibitor, Reduced HIV Viral Load and Increased CD4 Cell ... Tuesday, August 5, 2008 @ 12:01PM WHITEHOUSE STATION, N.J.----ISENTRESS® , Merck & Co., Inc.'s first-in-class integrase inhibitor, in combination with two other anti-HIV medicines, reduced HIV viral load to undetectable levels in 83 percent of previously untreated HIV-infected patients which was comparable to that seen with efavirenz *, which reduced HIV viral load to undetectable levels in 84 percent of treatment-naive ...
  • Growth hormone cuts abnormal fat in patients with HIV Monday, August 4, 2008 @ 2:23AMBut the treatment may produce an unnecessary risk for those who have early stages of diabetes, researchers say. Low doses of human growth hormone can reverse some of the abnormal fat distribution caused by HIV therapy, lowering the risk of cardiovascular disease, but the treatment may produce an unnecessary risk for those who have early stages of diabetes, researchers said Sunday.
  • Nation/World Briefs Monday, August 4, 2008 @ 1:28AMSAN FRANCISCO -- The FBI is investigating two firebombings targeting scientists at the University of California, Santa Cruz, as the latest in a rash of attacks against biomedical researchers who experiment on animals, authorities said. One scientist and his family, including two small children, were forced to flee from a second-story window after a firebomb was lit on their front porch, filling ...
  • This little drug went to market Wednesday, July 30, 2008 @ 5:27PMSleep deprived for decades, Kate Adams was in no mood to miss out on even a minute's sleep after joining a clinical trial of a new anti-insomnia drug.
  • HEALTH HAPPENINGS Tuesday, July 29, 2008 @ 1:01AMSend information about free or low-cost health-related events open to the public by noon Monday, one week ahead of publication. Information can be e-mailed to accent@bradenton.com . Complete listings can be found at Bradenton.com. All addresses are Bradenton, unless otherwise noted.
  • NEJM: Low-fat diets not best for weight loss: New study by Ben-Gurion U. of the Negev Wednesday, July 16, 2008 @ 5:08PMThe study was conducted by BGU and the Nuclear Research Center in Dimona, Israel, in collaboration with Harvard University, The University of Leipzig, Germany and the University of Western Ontario, Canada.
  • To Manage Your Cholesterol, Know Your Lipid Levels Tuesday, July 8, 2008 @ 5:11PM(ARA) - Are you confused about cholesterol? Wondering which numbers need to go up and which numbers need to go down? If so, you're not alone.
  • UI scientist writes book of simple truths about food Sunday, July 6, 2008 @ 10:28AM URBANA – First the nutrition gurus told us we shouldn't eat butter because it's an artery-clogging saturated fat. Then they told us to watch out for margarine because it's an artery-clogging trans fat.
  • Fatty liver disease may increase heart disease risk in overweight, obese kids Tuesday, July 1, 2008 @ 6:15AMWashington, July 1 : Overweight or obese kids with fatty liver disease might be at an increased risk of developing heart disease in later life, suggests a new study.
  • Fatty liver may raise heart disease risk in obese kids Tuesday, July 1, 2008 @ 3:43AMWashington, July 1: Fatty liver in overweight or obese children might be a precursor of cardiovascular disease, says a new study.
  • Still giving in tough times Thursday, June 26, 2008 @ 1:54AMIt's nice to know that even in troubled economic times, our communities still flourish with folks willing to help those truly in need.
  • Can fruit make you fat? Natural sugar found in fruit is 'fuelling the nation's obesity epidemic' Wednesday, June 25, 2008 @ 11:04PMA natural sugar found in fruit is fuelling the obesity epidemic, scientists say. A study has shown that fructose - which is used to sweeten soft drinks and junk food - might be more harmful than other types of sugar.
  • EU Approves Boosted Reyataz(R) (Atazanavir Sulphate), In Combination With Other Antiretroviral Medicines, For Treating ... Wednesday, June 25, 2008 @ 5:16AMThe European Commission has granted marketing authorization for REYATAZ® (atazanavir sulphate 300mg once daily), administered with ritonavir 100 mg once daily and taken in combination with other antiretroviral medicinal products, in antiretroviral treatment-naïve human immunodeficiency virus-1 (HIV-1) infected adults.
  • Tests for heart disease biomakers Monday, June 23, 2008 @ 7:57AMDoctors have a range of tests for biomarkers that can indicate potential cardiac problems and help prevent them. The best predictors are:
  • Cardiovascular Risk Assessment, Treatment Vital For HIV Patients On Therapy Monday, June 23, 2008 @ 7:18AMAntiretroviral medications have dramatically reduced the overall death rate among patients with the human immunodeficiency virus (HIV), but those same patients may now face an increased risk for cardiovascular disease (CVD), according to a group of experts who gathered to review the unique CVD risks experienced by people living with HIV and AIDS.
  • OLANZAPINE LONG-ACTING INJECTION (LAI) DATA PRESENTED AT FIRST ANNUAL SCHIZOPHRENIA INTERNATIONAL RESEARCH SOCIETY ... Monday, June 23, 2008 @ 3:56AMATTENTION EDITOR,
  • Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society ... Monday, June 23, 2008 @ 2:44AMEfficacy and safety data were generally consistent with oral olanzapine with the exception of injection-related events Results from olanzapine long-acting injection (LAI) clinical trials sh
  • Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society ... Monday, June 23, 2008 @ 2:00AM Results from olanzapine long-acting injection clinical trials showed that the efficacy and safety profile of olanzapine LAI was generally consistent with that of Zyprexa® with the exception of injection-related events.
  • Testosterone Replacement Benefits Older Men With Low Testosterone, Studies Suggest Monday, June 23, 2008 @ 12:11AMIn older men with low testosterone levels, testosterone replacement therapy improves their risk factors for cardiovascular disease and diabetes, according to two new studies.
  • Metabasis Announces Promising Results From Its Phase 1b Clinical Trial For MB07811, Its Novel Product Candidate For ... Saturday, June 21, 2008 @ 7:01AMMetabasis Therapeutics, Inc. (Nasdaq:MBRX) announced the results of its 14-day, Phase 1b multiple-dose clinical trial in subjects with mild hypercholesterolemia, which showed that MB07811 was safe and well tolerated across the seven doses tested, ranging from 0.25 mg up to 40 mg.